BMO Capital on Exelixis (EXEL): 'we do not expect a cabo generic entry by MSN until at least the latest...' Oct 15, 2024 02:32PM
BMO Capital Reiterates Outperform Rating on Exelixis (EXEL) May 20, 2024 09:56AM
Teva Pharma (TEVA) PT Lowered to $9 at BMO Capital Aug 9, 2019 08:20AM
Teva Pharma (TEVA) PT Lowered to $17 at BMO Capital May 3, 2019 08:49AM
BMO Capital Reiterates Outperform Rating on Eli Lilly (LLY) Following Teva's Failure Apr 23, 2019 10:22AM


Mar 28, 2019 02:10AM BMO Capital Starts Teva Pharma (TEVA) at Market Perform
Jul 13, 2017 08:52AM If AstraZeneca (AZN) Soriot Rumors are True, It Becomes a Pfizer (PFE) Acquisition Target Again; Negative for Bristol-Myers (BMY)
Nov 9, 2016 12:03PM Complete Donald Trump Stock Impact Guide
Nov 4, 2016 10:27AM Notable Analyst Rating Changes 11/4: (ACHN) (MMC) (HCP) Upgraded; (AXL) (BRO) (WFM) Downgraded
Jul 28, 2015 07:07AM BMO Capital Starts Teva Pharma (TEVA) at Outperform
Mar 11, 2015 11:33AM Mylan (MYL) Off Highs as Rumors Questioned
Nov 4, 2013 10:44AM Notable Analyst Rating Changes 11/04: (X) (GTI) (KSS) Upgraded; (BPI) (GPS) (AFL) Downgraded
Sep 13, 2013 10:20AM Notable Analyst Rating Changes 09/13: (AET) (INTC) (SWY) Upgraded; (ALU) (TEVA) (RIG) Downgraded
May 9, 2013 05:43PM BMO Capital Starts Teva Pharma (TEVA) at Outperform
Apr 19, 2011 10:44AM Notable Analyst Rating Changes 04/19: (ZION) (NAV) (RBN) Upgraded; (GS) (ABAT) (CRU) Downgraded
Dec 7, 2009 11:07AM Notable Analyst Rating Changes 12/07: POT, BRCD, SPWRA, STP, JASO, AXP Upgraded; MMC, ABX, ALTH, AVP, ZLC Downgraded
Mar 13, 2009 10:16AM David Moenning's Daily State of the Markets: 3/13
Dec 17, 2008 09:48AM David Moenning's Daily State of the Markets: 12/17